ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 207 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 2.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,000,000 | $76,440,000 | 25.99% |
| Opaleye Management Inc. | 1,660,000 | $10,574,000 | 9.12% |
| Camber Capital Management LP | 5,000,000 | $31,850,000 | 2.09% |
| Granite Point Capital Management, L.P. | 450,000 | $2,867,000 | 1.97% |
| Elk Creek Partners, LLC | 627,968 | $4,000,000 | 1.09% |
| Palo Alto Investors LP | 2,275,603 | $14,496,000 | 1.08% |
| Geduld E E | 245,100 | $1,561,000 | 0.97% |
| Rhenman & Partners Asset Management AB | 390,000 | $2,484,000 | 0.74% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 627,480 | $3,997,000 | 0.64% |
| GENERAL AMERICAN INVESTORS CO INC | 1,200,000 | $7,644,000 | 0.62% |